<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36836605</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">371</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm13020371</ELocationID><Abstract><AbstractText>Long-COVID syndrome is associated with high healthcare costs, but its pathophysiology is not yet fully understood. Inflammation, renal impairment or disturbance of the NO system emerge as potential pathogenetic factors. We aimed to investigate the relationship between symptoms of long-COVID syndrome and serum levels of cystatin-c (CYSC), orosomucoid (ORM), l-arginine, symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA). A total of 114 patients suffering from long-COVID syndrome were included in this observational cohort study. We found that serum CYSC was independently associated with the anti-spike immunoglobulin (S-Ig) serum level (OR: 5.377, 95% CI: 1.822-12.361; <i>p</i> = 0.02), while serum ORM (OR: 9.670 (95% CI: 1.34-9.93; <i>p</i> = 0.025) independently predicted fatigue in patients with long-COVID syndrome, both measured at baseline visit. Additionally, the serum CYSC concentrations measured at the baseline visit showed a positive correlation with the serum SDMA levels. The severity of abdominal and muscle pain indicated by patients at the baseline visit showed a negative correlation with the serum level of L-arginine. In summary, serum CYSC may indicate subclinical renal impairment, while serum ORM is associated with fatigue in long-COVID syndrome. The potential role of l-arginine in alleviating pain requires further studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zavori</LastName><ForeName>Laszlo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1715-4167</Identifier><AffiliationInfo><Affiliation>Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molnar</LastName><ForeName>Tihamer</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6149-9787</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varnai</LastName><ForeName>Reka</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8440-3955</Identifier><AffiliationInfo><Affiliation>Department of Primary Health Care, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanizsai</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Dentistry, Medical School, Pecs, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Lajos</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Applied Chemistry, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vadkerti</LastName><ForeName>Bence</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Applied Chemistry, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szirmay</LastName><ForeName>Balazs</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarcz</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csecsei</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4982-2481</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical School, University of Pecs, 7624 Pecs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cystatin-c</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">l-arginine</Keyword><Keyword MajorTopicYN="N">long-COVID syndrome</Keyword><Keyword MajorTopicYN="N">orosomucoid</Keyword><Keyword MajorTopicYN="N">renal function</Keyword><Keyword MajorTopicYN="N">symmetric dimethylarginine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>3</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36836605</ArticleId><ArticleId IdType="pmc">PMC9958557</ArticleId><ArticleId IdType="doi">10.3390/jpm13020371</ArticleId><ArticleId IdType="pii">jpm13020371</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE Guideline. 2020.  [(accessed on 1 January 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Naturemedicine. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliaccio M.G., Di Mauro M., Ricciolino R., Spiniello G., Carfora V., Verde N., Mottola F.F., Coppola N., Vanvitelli COVID-19 Group Renal Involvement in COVID-19: A Review of the Literature. Infect. Drug Resist. 2021;14:895&#x2013;903. doi: 10.2147/IDR.S288869.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S288869</ArticleId><ArticleId IdType="pmc">PMC7943324</ArticleId><ArticleId IdType="pubmed">33707958</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M., Bell S., Forni L., Joannidis M., Koyner J.L., Liu K., Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat. Rev. Nephrol. 2021;17:751&#x2013;764. doi: 10.1038/s41581-021-00452-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00452-0</ArticleId><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>Copur S., Berkkan M., Basile C., Tuttle K., Kanbay M. Post-acute COVID-19 syndrome and kidney diseases: What do we know? J. Nephrol. 2022;35:795&#x2013;805. doi: 10.1007/s40620-022-01296-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-022-01296-y</ArticleId><ArticleId IdType="pmc">PMC8924729</ArticleId><ArticleId IdType="pubmed">35294747</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am. J. Kidney Dis. 2002;40:221&#x2013;226. doi: 10.1053/ajkd.2002.34487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2002.34487</ArticleId><ArticleId IdType="pubmed">12148093</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlipak M.G., Katz R., Sarnak M.J., Fried L.F., Newman A.B., Stehman-Breen C., Seliger S.L., Kestenbaum B., Psaty B., Tracy R.P., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann. Intern. Med. 2006;145:237&#x2013;246. doi: 10.7326/0003-4819-145-4-200608150-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-145-4-200608150-00003</ArticleId><ArticleId IdType="pubmed">16908914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A., Mangoni A.A., Cystatin C. COVID-19 severity and mortality: A systematic review and meta-analysis. J. Nephrol. 2022;35:59&#x2013;68. doi: 10.1007/s40620-021-01139-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-021-01139-2</ArticleId><ArticleId IdType="pmc">PMC8363863</ArticleId><ArticleId IdType="pubmed">34390479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Chen X., Chen J., Pan X., Xia P., Lin H., Du H. The predictive value of serum level of cystatin C for COVID-19 severity. Sci. Rep. 2021;11:21964. doi: 10.1038/s41598-021-01570-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01570-2</ArticleId><ArticleId IdType="pmc">PMC8578213</ArticleId><ArticleId IdType="pubmed">34754069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Li J., Liu Z., Chen D., Zhou L., Hu D., Li M., Long W., Huang Y., Huang J., et al. Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients. Front. Pharmacol. 2021;12:587816. doi: 10.3389/fphar.2021.587816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.587816</ArticleId><ArticleId IdType="pmc">PMC8019901</ArticleId><ArticleId IdType="pubmed">33828483</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;gdberg L., Wester L. Immunocalins: A lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta. 2000;1482:284&#x2013;297. doi: 10.1016/S0167-4838(00)00164-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4838(00)00164-3</ArticleId><ArticleId IdType="pubmed">11058769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceciliani F., Pocacqua V. The acute phase protein alpha1-acid glycoprotein: A model for altered glycosylation during diseases. Curr. Protein Pept. Sci. 2007;8:91&#x2013;108. doi: 10.2174/138920307779941497.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920307779941497</ArticleId><ArticleId IdType="pubmed">17305563</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo A., Varzideh F., Wilson S., Gambardella J., Eacobacci M., Jankauskas S.S., Donkor K., Kansakar U., Trimarco V., Mone P., et al. l-Arginine and COVID-19: An Update. Nutrients. 2021;13:3951. doi: 10.3390/nu13113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113951</ArticleId><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannemann J., Balfanz P., Schwedhelm E., Hartmann B., Ule J., M&#xfc;ller-Wieland D., Dahl E., Dreher M., Marx N., B&#xf6;ger R. Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. Sci. Rep. 2021;11:9895. doi: 10.1038/s41598-021-89180-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89180-w</ArticleId><ArticleId IdType="pmc">PMC8110746</ArticleId><ArticleId IdType="pubmed">33972591</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleeman S.O., Cordioli M., Timmers P., Khan A., Tober-Lau P., Kurth F., Demichev V., Meyer H.V., Wilson J.F., Ralser M., et al. Cystatin C is associated with adverse COVID-19 outcomes in diverse populations. iScience. 2022;25:105040. doi: 10.1016/j.isci.2022.105040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105040</ArticleId><ArticleId IdType="pmc">PMC9428108</ArticleId><ArticleId IdType="pubmed">36062073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Xu E., Al-Aly Z. Kidney Outcomes in Long COVID. J. Am. Soc. Nephrol. 2021;32:2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X., Huang L., Cui D., Wang Y., Wang Y., Xu J., Shang L., Fan G., Cao B. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohortstudy. EBioMedicine. 2022;76:103817. doi: 10.1016/j.ebiom.2022.103817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103817</ArticleId><ArticleId IdType="pmc">PMC8776508</ArticleId><ArticleId IdType="pubmed">35074630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mussap M., Vestra M.D., Fioretto P., Saller A., Varagnolo M., Nosadini R., Plebani M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002;61:1453&#x2013;1461. doi: 10.1046/j.1523-1755.2002.00253.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2002.00253.x</ArticleId><ArticleId IdType="pubmed">11918752</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmersson-Karlqvist J., Lipcsey M., &#xc4;rnl&#xf6;v J., Bell M., Ravn B., Dardashti A., Larsson A. Cystatin C predicts long term mortality better than creatinine in a nationwide study of intensive care patients. Sci. Rep. 2021;11:5882. doi: 10.1038/s41598-021-85370-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85370-8</ArticleId><ArticleId IdType="pmc">PMC7961058</ArticleId><ArticleId IdType="pubmed">33723337</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T., Varnai R., Schranz D., Zavori L., Peterfi Z., Sipos D., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Buki A., Csecsei P. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. J. Clin. Med. 2021;10:4337. doi: 10.3390/jcm10194337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E., Politou M., Sergentanis T.N., Mentis A., Rosati M., Stellas D., Bear J., Hu X., Felber B.K., Pappa V., et al. Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study. Microorganisms. 2020;8:1885. doi: 10.3390/microorganisms8121885.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8121885</ArticleId><ArticleId IdType="pmc">PMC7760522</ArticleId><ArticleId IdType="pubmed">33260775</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund E., Leach S., Axelsson H., Nystr&#xf6;m K., Norder H., Bemark M., Angeletti D., Lundgren A., Nilsson S., Andersson L.M., et al. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS ONE. 2020;15:e0241104. doi: 10.1371/journal.pone.0241104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241104</ArticleId><ArticleId IdType="pmc">PMC7577439</ArticleId><ArticleId IdType="pubmed">33085715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kielstein J.T., Salpeter S.R., Bode-Boeger S.M., Cooke J.P., Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function&#x2014;A meta-analysis. Nephrol. Dial. Transplant. 2006;21:2446&#x2013;2451. doi: 10.1093/ndt/gfl292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl292</ArticleId><ArticleId IdType="pubmed">16766542</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Khoury J.M., Bunch D.R., Hu B., Payto D., Reineks E.Z., Wang S. Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function. Clin. Biochem. 2016;49:1140&#x2013;1143. doi: 10.1016/j.clinbiochem.2016.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2016.07.009</ArticleId><ArticleId IdType="pubmed">27452178</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Khoury J.M., Bunch D.R., Payto D., Reineks E., Wang S. Performance of Symmetric Dimethylarginine Against Other Markers of Kidney Function.  [(accessed on 1 January 2023)].  Available online:  https://www.msacl.org/2015_US_Long_Abstracts/201411071218_37806.pdf.</Citation></Reference><Reference><Citation>Fischer K., Kettunen J., W&#xfc;rtz P., Haller T., Havulinna A.S., Kangas A.J., Soininen P., Esko T., Tammesoo M.L., M&#xe4;gi R., et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: An observational study of 17,345 persons. PLoS Med. 2014;11:e1001606. doi: 10.1371/journal.pmed.1001606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001606</ArticleId><ArticleId IdType="pmc">PMC3934819</ArticleId><ArticleId IdType="pubmed">24586121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Zhang Z.X., Liu X. Orosomucoid (ORM) as a Potential Biomarker for the Diagnosis of Chronic Fatigue Syndrome (CFS) CNS Neurosci. Ther. 2016;22:251&#x2013;252. doi: 10.1111/cns.12522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12522</ArticleId><ArticleId IdType="pmc">PMC6492840</ArticleId><ArticleId IdType="pubmed">26833758</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas N.G., Broderick G., Fletcher M.A. Biomarkers for chronic fatigue. Brain Behav. Immun. 2012;26:1202&#x2013;1210. doi: 10.1016/j.bbi.2012.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2012.06.006</ArticleId><ArticleId IdType="pmc">PMC5373648</ArticleId><ArticleId IdType="pubmed">22732129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Y., Xiang K.F., Zhang H.M., Qin Z., Sun Y., Wan J.J., Gu W., Liu X. Orosomucoid: A promising biomarker for the assessment of exercise-induced fatigue triggered by basic combat training. BMC Sports Sci. Med. Rehabil. 2022;14:100. doi: 10.1186/s13102-022-00490-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13102-022-00490-6</ArticleId><ArticleId IdType="pmc">PMC9166395</ArticleId><ArticleId IdType="pubmed">35658935</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H., Sun Y., Luo Z., Yourek G., Gui H., Yang Y., Su D.F., Liu X. Fatigue-induced Orosomucoid 1 Actson C-C Chemokine Receptor Type 5 to Enhance Muscle Endurance. Sci. Rep. 2016;6:18839. doi: 10.1038/srep18839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep18839</ArticleId><ArticleId IdType="pmc">PMC4703980</ArticleId><ArticleId IdType="pubmed">26740279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni A.B., Reinke R., Feigelson P. Acute phase mediators and glucocorticoids elevate alpha 1-acid glycoprotein gene transcription. J. Biol. Chem. 1985;260:15386&#x2013;15389. doi: 10.1016/S0021-9258(17)36262-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)36262-2</ArticleId><ArticleId IdType="pubmed">2415519</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvin J., Pountain G.D., Hazleman B.L. Effect of short-term corticosteroid administration on the concentration of serum proteins. Ann. Clin. Biochem. 1995;32:213&#x2013;215. doi: 10.1177/000456329503200216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000456329503200216</ArticleId><ArticleId IdType="pubmed">7785953</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A., Ruiz-Ruig&#xf3;mez M., Laguna-Goya R., Arrieta-Ortubay E., Chivite-Lacaba M., Gonz&#xe1;lez-Cuadrado C., Lalueza A., Almendro-Vazquez P., Serrano A., Aguado J.M., et al. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID. Biomedicines. 2021;9:1540. doi: 10.3390/biomedicines9111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N., Goyal N., Nagaraja R., Kumar R. Systemic corticosteroids for management of &#x2018;long-COVID&#x2019;: An evaluation after 3 months of treatment. Monaldi Arch. Chest Dis. 2021;92 doi: 10.4081/monaldi.2021.1981.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2021.1981</ArticleId><ArticleId IdType="pubmed">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Mukherjee B., Castanheira A.M., Lam J.L., Benedetti G., Mak S.M., Preston R., Thillai M., Dewar A., Molyneaux P.L., et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann. Am. Thorac. Soc. 2021;18:799&#x2013;806. doi: 10.1513/AnnalsATS.202008-1002OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostorz-Nosal S., Jastrz&#x119;bski D., Chyra M., Kubicki P., Zieli&#x144;ski M., Ziora D. A prolonged steroid therapy may be beneficial in some patients after the COVID-19 pneumonia. Eur. Clin. Respir. J. 2021;8:1945186. doi: 10.1080/20018525.2021.1945186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20018525.2021.1945186</ArticleId><ArticleId IdType="pmc">PMC8231404</ArticleId><ArticleId IdType="pubmed">34221256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W., Beuschlein F., Bornstein S.R. Is there a role for the adrenal glands in long COVID? Nat. Rev. Endocrinol. 2022;18:451&#x2013;452. doi: 10.1038/s41574-022-00700-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00700-8</ArticleId><ArticleId IdType="pmc">PMC9150041</ArticleId><ArticleId IdType="pubmed">35637413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T.C., Tiwari A., Bonilla A.E., Miglis M., Yang P., Eggert L., Sharifi H., Horomanski A., Subramanian A., et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection.  [(accessed on 1 January 2023)];medRxiv. 2022  doi: 10.1101/2022.08.03.22278363. Available online:  https://www.medrxiv.org/content/10.1101/2022.08.03.22278363v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.03.22278363v1</ArticleId><ArticleId IdType="doi">10.1101/2022.08.03.22278363</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof S.L., Rutten J.M., Uiterwaal C.S., Bleijenberg G., Kimpen J.L., Putte E.M. The role of hypocortisolism in chronic fatigue syndrome. Psychoneuroendocrinology. 2014;42:199&#x2013;206. doi: 10.1016/j.psyneuen.2014.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2014.01.017</ArticleId><ArticleId IdType="pubmed">24636516</ArticleId></ArticleIdList></Reference><Reference><Citation>Harima A., Shimizu H., Takagi H. Analgesic effect of L-arginine in patients with persistent pain. Eur. Neuropsychopharmacol. 1991;1:529&#x2013;533. doi: 10.1016/0924-977X(91)90006-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0924-977X(91)90006-G</ArticleId><ArticleId IdType="pubmed">1822318</ArticleId></ArticleIdList></Reference><Reference><Citation>Rond&#xf3;n L.J., Farges M.C., Davin N., Sion B., Privat A.M., Vasson M.P., Eschalier A., Courteix C. L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration. Eur. J. Nutr. 2018;57:2353&#x2013;2363. doi: 10.1007/s00394-017-1508-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-017-1508-x</ArticleId><ArticleId IdType="pubmed">28725942</ArticleId></ArticleIdList></Reference><Reference><Citation>Severyanova L.A., Bobyntsev I.I., Kir&#x2019;yanova N.A., Dolgintsev M.E. Effects of L-arginine on various types of pain sensitivity. Bull. Exp. Biol. Med. 2006;141:567&#x2013;570. doi: 10.1007/s10517-006-0222-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10517-006-0222-0</ArticleId><ArticleId IdType="pubmed">17181054</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ger R.H., Bode-B&#xf6;ger S.M., Thiele W., Creutzig A., Alexander K., Fr&#xf6;lich J.C. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J. Am. Coll. Cardiol. 1998;32:1336&#x2013;1344. doi: 10.1016/S0735-1097(98)00375-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(98)00375-1</ArticleId><ArticleId IdType="pubmed">9809945</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajapakse N.W., Mattson D.L. Role of L-arginine in nitric oxide production in health and hypertension. Clin. Exp. Pharmacol. Physiol. 2009;36:249&#x2013;255. doi: 10.1111/j.1440-1681.2008.05123.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2008.05123.x</ArticleId><ArticleId IdType="pubmed">19076168</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo C., Visco V., Gambardella J., Ferruzzi G.J., Rispoli A., Rusciano M.R., Toni A.L., Virtuoso N., Carrizzo A., Di Pietro P., et al. Cardiovascular implications of miRNAs in COVID-19. J. Pharmacol. Exp. Ther. 2022;384:102&#x2013;108. doi: 10.1124/jpet.122.001210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001210</ArticleId><ArticleId IdType="pubmed">35779946</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittmann F., Prix N., Mayr S., Angele P., Wichmann M.W., van den Engel N.K., Hernandez-Richter T., Chaudry I.H., Jauch K.W., Angele M.K. L-arginine improves wound healing after trauma-hemorrhage by increasing collagen synthesis. J. Trauma. 2005;59:162&#x2013;168. doi: 10.1097/01.TA.0000171529.06625.A8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000171529.06625.A8</ArticleId><ArticleId IdType="pubmed">16096557</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz D., Lipoldov&#xe1; M., Reinecke H., Sohrabi Y. Targeting inflammation with collagen. Clin. Transl. Med. 2022;12:e831. doi: 10.1002/ctm2.831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.831</ArticleId><ArticleId IdType="pmc">PMC9126324</ArticleId><ArticleId IdType="pubmed">35604877</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>